Accellta CEO Itzchak Angel speaks to Informa senior editor and writer Sten Stovall during the BIO-Europe Spring® partnering conference in Stockholm, Sweden about the Israeli stem cell specialist's stem cell culturing process and future expansion plans including a planned USD 15 million capital-raising exercise and ongoing search for future corporate partners. The potential applications of Accellta's technologies include the development of cell-based medical therapies, research tools and methods, drug screening and development and tissue engineering.
Want to elevate your brand and connect with potential partners? The Cell & Gene Exchange brings together leaders from patient advocacy groups, industry, academia and government to network, exchange ideas and explore partnership opportunities. Learn more here.